[1. Johnson RD, Pai VC, Hoft RH. (2012). Historical approaches to pterygium surgery, including bare sclera and adjunctive beta radiation techniques. In: Hovanesian JA, editor. Pterygium: Techniques and Technologies for Surgical Success. Thorofare, NJ: Slack Incorporated: 27–36.]Search in Google Scholar
[2. Luthra R, Nemesure B, Wu S, Xie S, Leske M. (2001). Frequency and risk factors for pterygiumin the Barbados Eye Study. Arch Ophthalmol.119:1827-3210.1001/archopht.119.12.1827]Search in Google Scholar
[3. Cameron M. (1965). Pterygium Throughout the World. Edited by Thomas CC. Illinois: Springfield.]Search in Google Scholar
[4. Vojnikovic B, Njiric S, Cocklo M, Toth I, Spanjol J, Marinovic M. (2007). Sunlight and incidence of pterigium on Croatian Island Rab: epidemiological study. Coll Antropol, 31:61-2.]Search in Google Scholar
[5. K. R. Kenyon, M. D. Wagoner, and M. E. Hettinger. (1985). Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. vol. 92, no. 11, pp. 1461-70.10.1016/S0161-6420(85)33831-9]Search in Google Scholar
[6. J. Cano-Parra, M. Diaz-Liopis, M. J. Maldonado, E. Vila, and J. L. Menezo. (1995). Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium. British Journal of Ophthalmology. vol. 79, no. 5, pp. 439-41.10.1136/bjo.79.5.439]Search in Google Scholar
[7. Abiose A. (1997). Treatment of pterygium in Lagos, Nigeria. E Afr Med J. 54:327-31.]Search in Google Scholar
[8. Alpay A, Ugurbas SH, Erdogan B. (2009). Comparing techniques for pterygium surgery. Clin Ophthalmol. 3:69-74.]Search in Google Scholar
[9. Apaydin KC, Duranoglu Y, Saka O, Demirbas N. (2002). Argon laser treatment of pterygium. Ann Ophthalmol. 34:26-9.]Search in Google Scholar
[10. Krag S, Ehlers N. Excimer laser treatment of pterygium. (2009). Acta Ophthalmologica. 70:530-3.]Search in Google Scholar
[11. Chen KH, Hsu WM. (2006). Intraoperative ethanol treatment as an adjuvant therapy of pterygium excision. Int J Biomed Sci. 2:413-20]Search in Google Scholar
[12. Kaufman SC, Jacobs DS, Lee WB, Deng SX, Rosenblatt MI, Shtein RM. (2013). Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology. Ophthalmology. 120(1):201-8.]Search in Google Scholar
[13. Jurgenliemk-Schulz IM, Hartman LJ, Roesink JM, Tersteeg RJ, Van der Tweel, Kal HB, et al. (2004). Prevention of pterygium recurrence by postoperative single dose beta irradiation: A prospective randomized clinical double blind trial. Int J Rad Oncol. 59:1138-47.]Search in Google Scholar
[14. Ajayi BG, Bekibele CO. (2002). Evaluation of the effectiveness of postoperative beta irradiation in the management of pterygium. Afr J Med Med Sci. 31:9-11.]Search in Google Scholar
[15. Walter WL. (1994). Another look at pterygium surgery with postoperative beta radiation. Ophthal Plast Reconstr Surg. Dec; 10(4):247-52.]Search in Google Scholar
[16. Chapman-Smith JS. (1992). Pterygium treatment with triethylene thiophosphoramide. Aust NZJ Ophthalmol. 20:129-3110.1111/j.1442-9071.1992.tb00724.x]Search in Google Scholar
[17. Sodhi PK, Verma L, Pandey RM, Ratan S. (2004). Comparison between the role of intraoperative mitomycin C and doxorubicin in preventing the recurrence of primary pterygium. Ophthalmic Res. 37:1-6.]Search in Google Scholar
[18. Wu PC, Kuo HK, Tai MH, Shin SJ. (2009). Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium. Cornea. 28:103-4]Search in Google Scholar
[19. Detorakis ET, Zaravinos A, Spandidos DA. (2010). Growth factor expression in ophthalmic pterygia and normal conjunctiva. Int J Mol Med. 25:513-6.]Search in Google Scholar
[20. Alyaà Abood Kareem, Qasim Kadhim Farhood, Hussein Ali Alhammami. (2012). The use of antimetabolites as adjunctive therapy in the surgical treatment of pterygium. Clinical Ophthalmology. 6 1849-54.]Search in Google Scholar
[21. Sutphin JE. (2008). Basic and Clinical Science Course: External disease and cornea. San Francisco:American Academy of Ophthalmology. 8: 394, 429-32.]Search in Google Scholar
[22. Almond MC, Dastrup BT, Kaufman SC. (2012). 5-fluorouracil and mitomycin-C: adjuncts to pterygium surgery. In: Hovanesian JA, editor. Pterygium: Techniques and Technologies for Surgical Success. Thorofare, NJ: Slack Incorporated. 55-64.]Search in Google Scholar
[23. Ang LP, Chua JL, Tan DT. (2007). Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol. 18:308-13.]Search in Google Scholar
[24. de la Hoz F, Montero JA, Alio JL, Javaloy J, Ruiz-Moreno JM, Sala E. (2008). Efficacy of mitomycin C associated with direct conjunctival closure and sliding conjunctival graft for pterygium surgery. Br J Ophthalmol. 92:175-8.]Search in Google Scholar
[25. Brazowski E, Eytan K, Eisenthal A. (2007). In vitro modulation of interleukin-2-mediated human peripheral mononuclear cell proliferation and antitumor cytotoxicity by 5-fluorouracil. Anticancer Res. 27(6B): 4135-41.]Search in Google Scholar
[26. Wu PC, Kuo HK, Tai MH, Shin SJ. (2009). Topical bevacizumab eye drops for limbal conjunctival neovascularization in impending recurrent pterygium. Cornea. 28(1):103-4.]Search in Google Scholar
[27. Lekhanont K, Patarakittam T, Thongphiew P, Suwanapichon O, Hanutsaha P. (2012). Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent Pterygium: a pilot study. Cornea. 31(12):155-61.]Search in Google Scholar
[28. Koenig Y, Bock F, Horn F, Kruse F, Straub K, Cursiefen C. (2009). Short and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol. Oct, 247(10):1375-82.]Search in Google Scholar
[29. K. Jae, K. Dong, K. Eun-Soon, J. K. Myoung, and T. Hungwon. (2013). Topically administered bevacizumab had longer standing antiangiogenic effect than subconjunctivally injected bevacizumab in rat corneal neovascularization. International Journal of Ophthalmology, vol. 6, no. 5, pp. 588-91.]Search in Google Scholar
[30. Comstock TL, Decory HH. (2012). Advances in corticosteroid therapy for ocular inflammation: loteprednol etabonate. Int J Inflam. 2012:789623. doi: 10.1155/2012/789623.10.1155/2012/789623]Search in Google Scholar
[31. Alberth M, Wu WM, Winwood D, Bodor N. (1991). Lipophilicity, solubility and permeability of loteprednol etabonate: a novel, soft anti-inflammatory steroid. J Biopharm Sci. 2(2):115-25.]Search in Google Scholar
[32. Wu WM, Huang F, Lee Y, Buchwald P, Bodor N. (2008). Pharmacokinetics of the sequential metabolites of loteprednol etabonate in rats. J Pharm Pharmacol. 60(3):291-7.]Search in Google Scholar
[33. Nguyen HT, Samudre SS, Lattanzio FA, Williams PB, Sheppard JD. (2008). Loteprednol etablonate reduces Inflammatory Response associated with Pterygium Progression. Investig Ophthalmol Vis Sci 49: 6027.]Search in Google Scholar
[34. Karalezli A, Kucukerdonmez C, Akova YA, Yaycioglu RA, Borazan M. (2008). Fibrin glue versus sutures for conjunctival autografting in pterygium surgery: A Prospective comparative study. Br J Ophthalmol. 92:1206-10.]Search in Google Scholar
[35. Srinivasan S, Dollin M, McAllum P, Berger Y, Rootman DS, Slomovic AR. (2009). Fibrin glue versus sutures for attaching the conjunctival autograft in pterygium surgery: A prospective observer masked clinical trial. Br J Ophthalmol. 93:215-8.]Search in Google Scholar
[36. Cho H, Chuck RS. (2012). Pterygium excision and placement of amniotic membrane grafts. In: Hovanesian JA, editor. Pterygium: Techniques and Technologies for Surgical Success. Thorofare, NJ: Slack Incorporated. 91-100.]Search in Google Scholar
[37. Tananuvat N, Martin T. (2004). The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea. 23:458-63.]Search in Google Scholar
[38. Kenyon KR, Wagoner MD, Hettinger ME. (1985). Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 92:1461-7010.1016/S0161-6420(85)33831-9]Search in Google Scholar
[39. Kavita Mallikarjun Salagar, Kalyanappa Gurlingappa Biradar. (2013). Conjunctival Autograft in Primary and Recurrent Pterygium. Journal of Clinical and Diagnostic Research. Dec, Vol-7(12): 2825-7.]Search in Google Scholar
[40. Koranyi G, Artzen D, Seregard S, Kopp ED. (2012). Intraoperative mitomycin C versus autologous conjunctival autograft in surgery of primary pterygium with 4 year follow up. Acta Ophthalmol. May;90(3):266-70.]Search in Google Scholar
[41. Abdallah WM. (2009). Efficacy of limbal-conjunctival autograft surgery with stem cells in pterygium treatment. Mid E Afr J Ophthalmol. 16:260-2.]Search in Google Scholar
[42. Katircioglu YA, Altiparmak UE, Duman S. (2007). Comparison of three methods for the treatment of pterygium: Amniotic membrane graft, conjunctival autograft and autograft plus mitomycin C. Orbit. 26:5-13.]Search in Google Scholar
